Why are pharma, medical device and DTx companies investing in telemedicine?
One virtual care CEO says telehealth is improving care for rare and complex diseases, helping compounding pharmacists – and continually improving with artificial intelligence.
One virtual care CEO says telehealth is improving care for rare and complex diseases, helping compounding pharmacists – and continually improving with artificial intelligence.
Go to Source
2025-02-04 22:52
Except for the headline, this story has not been edited by Healthcare Central is published from a syndicated feed.
